About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Phoenix | 174 Studies

Clinical Trials HypertensionPhoenix

Hypertension Clinical Trials in Phoenix

Find 174 clinical trials for hypertension near Phoenix, Arizona. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 174 trials

CompletedStudy of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular HypertensionTo test the safety and effectiveness of AR-13324 0.02% and 0.04% ophthalmic solution relative to placebo in Japanese/Japanese-American subjects with open-angle glaucoma or ocular…NCT03310580·Chandler, Arizona and 39 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionRecent hypertension guidelines recommend combination therapy as initial treatment for many or most patients.NCT04518293·Phoenix, Arizona and 88 others

CompletedThe Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionThe objective of this clinical trial is to compare the efficacy and safety of an initial triple oral treatment regimen (macitentan, tadalafil, selexipag) versus an initial dual…NCT02558231·Phoenix, Arizona and 57 others

Active not recruitingALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS PlacementALTA is a multicenter consortium focused on the management of portal hypertension.NCT03973372·Phoenix, Arizona and 13 others

CompletedEfficacy Study of Digibind for Treatment of Severe PreeclampsiaThe purpose of this study is to determine whether a commercially available anti-digoxin antibody, Digibind, can delay delivery in patients with severe pre-eclampsia.NCT00158743·Mobile, Alabama and 7 others

TerminatedAn Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFEThis is a multicenter, open-label trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension (PH) associated with…NCT02633293·Birmingham, Alabama and 91 others

CompletedZilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and hypertension not adequately controlled by…NCT06272487·Alexander City, Alabama and 194 others

CompletedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 StudyThis is a Phase III, randomized, double-masked, active-controlled, parallel-group, multi-center study.NCT03691649·Phoenix, Arizona and 46 others

Active not recruitingA Study of Mosliciguat in PH-ILDThis is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with…NCT06635850·Phoenix, Arizona and 84 others

CompletedAn Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial HypertensionThis study provided/continued to provide oral treprostinil (UT-15C SR; treprostinil diethanolamine) to eligible subjects who participated in Studies TDE-PH-202, TDE-PH-203…NCT01027949·Birmingham, Alabama and 133 others

CompletedPhase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral MonotherapyThis is an international, multicenter, randomized, double-blind, placebo-controlled, event driven study in subjects with pulmonary arterial hypertension.NCT01560624·Phoenix, Arizona and 154 others

CompletedA Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)The purpose of this study is to assess the safety and efficacy of Rodatristat Ethyl in pulmonary arterial hypertension (PAH) patients.NCT04712669·Phoenix, Arizona and 63 others

TerminatedIloprost Power Disc-15 in Pulmonary Arterial HypertensionA Phase IIIb, Multicenter, Open-Label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When…NCT00723554·Mobile, Alabama and 35 others

CompletedOlmesartan Comparison to Losartan in Hypertensive SubjectsThis study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.NCT00949884·Mesa, Arizona and 19 others

TerminatedDORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionThis is a double-blind, active-controlled, long-term study of a new experimental drug called darusentan.NCT00389675·Birmingham, Alabama and 98 others

CompletedA 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaTo demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure…NCT00159653·Phoenix, Arizona and 54 others

CompletedDose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential HypertensionThe main objective will be to evaluate the dose-response of ACT-132577 (aprocitentan) on diastolic blood pressure (DBP) in participants with grade 1 or 2 essential hypertension.NCT02603809·Fort Payne, Alabama and 89 others

CompletedEfficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionRecent hypertension guidelines recommend combination therapy as initial treatment for many or most patients.NCT04518306·Phoenix, Arizona and 46 others

CompletedEfficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionThe purpose of this study is to determine the efficacy and safety of azilsartan medoxomil combined with chlorthalidone, once daily (QD), in participants with moderate to severe…NCT00847626·Birmingham, Alabama and 98 others

CompletedPatiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)The purpose of this study is to assess the effects of patiromer compared with placebo on serum K+ in HF patients.NCT03888066·Alexander City, Alabama and 414 others

PreviousPage 8 of 9Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia